Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5 |
||
Associations of SCORE2 and circulating cardiovascular biomarkers - Insights from the population-based Hamburg City Health Study | ||
B. Toprak1, J. Lehmacher1, Y. Hu2, C. Waldeyer1, T. Zeller3, S. Blankenberg1, J. T. Neumann1, R. Twerenbold3, für die Studiengruppe: HCHS | ||
1Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 2Cardio-CARE AG, Davos, Schweiz; 3Klinik für Kardiologie und University Center of Cardiovascular Science, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; | ||
Background: The European Society of Cardiology (ESC) recently published an updated version of the Systematic Coronary Risk Evaluation (SCORE2) model to estimate the 10-year risk of fatal and non-fatal cardiovascular events based on traditional cardiovascular risk factors. Although circulating cardiovascular biomarkers are known to be predictive for incident cardiovascular diseases (CVD) in the general population beyond traditional risk factors, they are still largely missing in long-term risk prediction models such as SCORE2.
Conclusions: All investigated circulating cardiovascular biomarkers depicting different pathophysiological mechanisms correlate well with the long-term cardiovascular risk estimated by SCORE2. Their additive value in future risk models might help to further improve and personalize cardiovascular risk prediction in the general population. |
||
https://dgk.org/kongress_programme/jt2022/aP876.html |